Adenomyosis and endometrial cancer - exploratory study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030376

Enrollment

150

Registered

2023-01-16

Start date

2022-12-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis, endometrial cancer

Interventions

Group 1: Comparison between three cohorts - endometrial cancer alone, endometrial cancer + adenomyosis, adenomyosis alone

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Hysterectomy histological specimens from patients operated at KUK in the years 2010 - 2021

Exclusion criteria

Exclusion criteria: damaged specimens, Patients who underwent a chemo- or radiotherapy

Design outcomes

Primary

Measure	Time frame
significant differences in collected parameters or in the occurrence of immunohistochemical markers	—

Countries

Austria

Contacts

Public ContactNatalia Palasz

Kepler Universitätsklinikum

natalia.palasz@kepleruniklinikum.at+43 69917172546

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026